Dihydroboldenone vs Sustanon 250
A side-by-side research comparison of Dihydroboldenone and Sustanon 250 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dihydroboldenone | Sustanon 250 |
|---|---|---|
| Full name | Dihydroboldenone (1-Testosterone / DHB) | Sustanon 250 (Testosterone Ester Blend) |
| Category | Anabolic Steroids | Anabolic Steroids |
| Status | Not medically approved (controlled substance) | Prescription drug (controlled substance) |
| Mechanism | DHB is boldenone with the double bond reduced, giving a highly anabolic, non-aromatizing steroid that does not convert to estrogen or DHT. It has strong androgen-receptor binding and promotes dry, lean gains. | Combines short, medium, and long esters so testosterone is released at staggered rates, producing a rapid initial rise followed by sustained levels. The active hormone is standard testosterone acting on androgen receptors. |
| Molecular weight | 288.4 Da (base) | Blend (varies by ester) |
| Half-life | Varies by ester | Mixed (~1 day to ~2 weeks across esters) |
| Bioavailability | Intramuscular injection | Intramuscular injection |
| Typical dose | Lean-gain cycles (non-medical) | Medical: ~250 mg every 2-3 weeks (varies) |
| Frequency | Per ester | Every 1-3 weeks (medical) |
| Route | Intramuscular injection | Intramuscular injection |
Dihydroboldenone reported benefits
- Strong lean mass gains
- No estrogen conversion
- No DHT conversion
- Dry, hard appearance
Sustanon 250 reported benefits
- Fast onset plus long duration
- Single-product convenience
- Restores testosterone (medical)
- Muscle mass and strength
Related comparisons
Research and educational reference only. Not medical advice.